skip to main content

Commentary

Mitt Romney Fails the Pro-Life Community

February 24th, 2022

LifeNews has an article running now on the impact of expanded access to RU-486, the chemical abortion pill.  Under the guise of the “pandemic”, the FDA shelved many health care protections for women and girls. 

Since RU-486 was first approved under Bill Clinton, the FDA has required in-person examinations by a doctor before women and girls are given pills to induce a chemical abortion.  There are very good reasons for this, as dozens of women have died has a result of complications from the very powerful drugs.  The FDA has always restricted the drugs to women prior to the 70th day of their pregnancy.

But last December, the FDA lifted the in-person requirement.  That means no health care professional can diagnose the gestational age of the baby, increasing the health risks.  Planned Parenthood has taken full advantage of this change, trading women’s health for their profit.

LifeNews reports that 125 members of Congress have written a letter to the new FDA Commissioner, asking that the FDA restore restrictions on the dispensing of RU-486.  That letter cites new statistics, published in November of 2021, showing that emergency room visits following self-abortions using RU-486 have increased by a staggering 500% from 2002 to 2015.

The shameful conduct of the FDA during the COVID crisis was no great surprise to us.  For years, we have watched politics and outside groups influence their decision making around abortion.

There was an opportunity to take a stand against the corruption of the FDA last week.  Mr. Biden had nominated Dr. Robert Califf to be his guy at the helm.  It is no surprise that Dr. Califf has a long and radical commitment to Planned Parenthood and abortion-on-demand.

Despite the chilling data presented by members of Congress, there is little chance that Dr. Califf will defy Planned Parenthood and protect the health of women and girls.

The infuriating part of this story is that Dr. Califf would not be in charge of the FDA had Sen. Mitt Romney not capitulated in voting to confirm him as the new Commissioner last week.  His nomination would have been defeated except for the inexplicable support given him by Sens. Romney and Susan Collins.